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Introduction
Determining crystallographic phases remains a key step in
the solution of macromolecular structures. For most novel
structures, phases must be determined experimentally using
methods that rely on finding the positions of a few special
(either electron-dense ‘heavy’, or anomalously scattering)
atoms. The scattering contribution of these atoms, in combi-
nation with knowledge of their positions, can be used to cal-
culate phases for the total crystal contents. Whether these
calculations rely on multiple wavelength anomalous disper-
sion (MAD), multiple isomorphous replacement (MIR),
single isomorphous replacement with anomalous scattering
(SIRAS) or other methods will depend entirely on the
ordered presence of these special atoms. Thus, the ability to
efficiently prepare samples containing such sites is of funda-
mental importance in macromolecular crystallography.
Incorporation of selenium atoms in proteins via selenome-
thionine (SeMet) has become a staple method for protein
crystallography [1]. However, in some cases, SeMet MAD
is not an appropriate method for phase determination [2].
Thus screening for phasing atoms is still an indispensable
arrow in the crystallographer’s quiver. Although the
screening process has often been approached as a some-
what arbitrary collection of trial-and-error experiments,
recent advances have provided the basis for a more sys-
tematic experimental approach. Here we review methods
of screening for phasing atoms, with an emphasis on the
newer more systematic approaches that have streamlined
the process. In particular, we describe a novel method of
screening using native gel electrophoresis that enables
dozens of compounds to be analyzed in only a few hours.
A little forethought goes a long way
There is no a priori way to predict with certainty com-
pounds and conditions that will lead to the successful
derivatization of a protein crystal. For example, a protein
that contains free cysteine thiols is likely to be deriva-
tized by mercury compounds but will not always be.
Derivatization depends on the exposure of functional
groups, local chemical environment, ionization state, and
other parameters that can not be accurately foreseen,
especially in the absence of a high-resolution structure. 
Nonetheless, screening for derivatives can be directed
toward a higher likelihood of success by simple conjectures
based on known properties of the protein and the particulars
of the crystallization conditions. An additional consideration
concerns the X-ray diffraction properties of the phasing
atom to be incorporated. Different types of atom are best
suited to different types of diffraction experiments, and
derivative screening can be designed from the inception to
focus on the optimum scatterer for the chosen experiment.
The classic text describing the chemistry of derivatization
compounds remains Blundell and Johnson [3]. More recent
reviews (for example [4,5]) have expanded on this early
work. Blundell and Johnson designated compounds as
‘hard’ or ‘soft’. Hard ligands bind to their protein targets
without covalent modification. For example, the lanthanides
typically bind ionically via oxygen-containing sidechains
and carbonyls. Soft ligands — which often include platinum,
mercury and gold atoms — tend to bind covalently to
sulfhydryl, imidazole and thiol groups. Some of these com-
pounds have high specificity for particular sidechains, for
example, K2PtCl4 preferentially reacts with methionine and
many mercury compounds specifically target cysteine thiols.
A small subset of the available derivatization reagents are
responsible for a substantial portion of the structures deter-
mined using derivatized crystals. Statistics on derivatization
can be evaluated using the Heavy Atom Databank (HAD)
[6] (http://www.bmm.icnet.uk/had/heavyatom.html). Histor-
ically, the seven most successful compounds — occasionally
referred to as the ‘magic seven’ — have been K2PtCl4,
KAu(CN)2, K2HgI4, UO2(C2H3O2), HgCl2, para-chloro
mercury benzoic acid sulfonate (PCMBS) and K3UO2F5.
Whether these compounds are in fact better by nature, or
are simply statistically advantaged because of their early
arrival in protein crystallography, is not entirely clear.
The natural ligand-binding activities of some proteins can
be used for the incorporation of phasing atoms. Natural
metal centers containing iron, copper and zinc, (K edges at
1.74, 1.38 and 1.28 Å, respectively) have all been used for
the determination of protein structures using MAD. Ca2+
and Mg2+ binding are also common but their X-ray proper-
ties exclude their use as phasing atoms (K edges at 3.07
and 9.50 Å, respectively). Divalent cations, however, can
often be replaced with trivalent lanthanides (57La through
to 71Lu). The lanthanides have among the best X-ray
anomalous scattering properties of all atoms, often with 
f′ peaks at the LIII absorption edge as high as 30 electrons
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[7]. Lanthanide ions, however, form insoluble colloids
above neutral pH, and this excludes their use in some
cases. Bound phosphate ions can often be replaced by
tungstate [8,9], which has excellent MAD diffraction prop-
erties. More complex biological ligands have also been
used for the introduction of phasing atoms. For example,
the natural iodine of thyroid hormone was used to deter-
mine its receptor complex structure [10]. Phasing atoms
can also be incorporated into small-molecule ligands by
chemical or biological synthesis. This method was used in
the first selenium MAD experiment; seleno–biotin was
used as a phasing vehicle for the complex structure with
streptavidin [11]. Similarly, it has now become common
practice to use iodinated (for MIR) or brominated (for
MAD) nucleotides in the determination of structures of
nucleic acids and their complexes with proteins.
Molecular biology methods have also been useful for intro-
ducing phasing atoms. In addition to the standard method
of selenomethionine substitution for natively encoded
methionines [1], it is also possible to insert additional
methionines by mutagenesis in order to enhance the
phasing signal [12]. Some studies, relying on the avidity of
mercury atoms for free thiols, have used ectopic cysteine
residues — engineered for predicted surface accessibil-
ity — as covalent acceptors for phasing atoms [13,14].
Choice of atom type
Other than chemical reactivity properties, the best choice
of atom type will depend on diffraction properties. For
both anomalous scattering and isomorphous difference
experiments, the primary criterion will be whether the
change in total scattering brought about by derivatization
is large enough to be observed well experimentally. For
isomorphous differences, this is simply related to the
number of phasing atoms incorporated and their atomic
number. In 1956 Crick and Magdoff [15] showed that the
average expected intensity change from isomorphously
adding heavy atoms can be estimated shown in equation 1.
(1)
NH and NP refer to the number of heavy and protein
atoms respectively, ZH is the atomic number for the
heavy atom, and Zeff is the effective average atomic
number for a protein atom, about 6.7. This expression can
be evaluated prior to derivative screening to limit the
screen to atom choices likely to provide sufficient signal.
But what is sufficient signal? An effect about the value of
Rsym will be observable but larger signals are desirable.
Because Rsym increases with resolution, the signal esti-
mate is often best made for the highest resolution shell
for which phasing is likely, given the quality of the data.
For example, a single ordered 100% occupancy mercury
atom (Z = 80) bound to an 80 kDa protein should provide
about 21% isomorphous differences, whereas an yttrium
atom (Z = 39) would provide only about 10% differences.
Although an yttrium derivative could certainly be of
value, it is probable that data quality would limit its use-
fulness to lower resolution shells. It is often more prudent
to initially steer clear of such potential derivative atoms.
For anomalous scattering, the situation is similar [16].
The total scattering factor f for an anomalously scattering
atom can be expressed as the sum of a wavelength-inde-
pendent part f 0 and the real and imaginary components of
the anomalous scattering (equation 2).
f = f 0 + f′(λ) + i f′′(λ) (2)
f′ reflects changes in the ‘real’ scattering component (as do
isomorphous differences), whereas the f′′ value at a partic-
ular wavelength determines the strength of ‘imaginary’
anomalous scattering. The root mean square expected
signal from Bijvoet differences at a given wavelength λ
can be expressed as in equation 3.
(3)
NA is the number of anomalous scatterers. The dispersive
diffraction ratio between two wavelengths can be
expressed as equation 4.
(4)
NT is the total number of atoms, including anomalous
scatterers. Anomalous differences, in general, are smaller
than isomorphous differences, and anomalous scattering
behavior varies broadly among the elements. Hence
great care must be taken in the choice of element for
anomalous diffraction experiments. 
Because anomalous data is most often measured from a
single frozen crystal, non-isomorphism is usually near zero.
Furthermore, special geometries, such as inverse-beam and
mirror-alignment can minimize errors in collecting anom-
alous data so that errors on anomalous difference measure-
ments are substantially below Rsym. It is for these reasons
that a substantially lower signal can be tolerated in MAD
experiments as compared with isomorphous experiments.
For example, a rough rule of thumb has arisen that ~1
selenomethionine per 100 amino acids is sufficient for a
SeMet MAD experiment [16]. Using this equation, a signal
of only ~4% (for Bijvoet differences at the f′′ = 6e– Se peak)
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is predicted. Although this would certainly be inadequate
for most isomorphous experiments, it is well within the
realm of possibility for MAD data.
For MAD experiments the best derivative elements will
have large f′′ values at an absorption edge and large differ-
ences between f′ at different nearby wavelengths. These
conditions are met by elements with strong and sharp
(white line) X-ray absorption features. It is also necessary
that these edges fall within the appropriate energy range,
from ~0.5 Å (near the high-end of efficient X-ray produc-
tion for most synchrotron sources) to ~1.7 Å (above which
absorption effects become problematic). Among the best
anomalous scatterers are the actinides and lanthanides. Of
the actinides, all of which have predominant isotopes that
are radioactive, only 92U is commonly used in crystallogra-
phy, and can provide extraordinary LIII edge anomalous
signal at 0.7Å [7]. The lanthanides, 57La to 71Lu, have
strong white line absorption features at their LIII edges,
which increase in energy monotonically from 2.6 Å for 57La
to 1.3Å for 71Lu. Lanthanide Ln3+ ions typically bind ioni-
cally to proteins. They can often substitute for divalent
cations at specific protein-binding sites. Ln3+ ions across
the lanthanide series often exhibit remarkably similar
chemical behavior [17]. Thus, if one type of lanthanide ion
can substitute at a particular binding site, other types will
usually work as well. In this way, experiments can be
tuned to achieve optimal X-ray characteristics by employ-
ing a particular lanthanide. Samarium, for ex ample, pro-
vides the strongest Bijvoet differences (f′′ ~12e–) with
CuKα radiation; for synchrotron experiments lutetium pro-
vides the highest energy LIII transition, thus providing an
easy means to minimize absorption difficulties.
Covalent heavy-atom derivatives of proteins can often be
obtained by reacting with compounds containing elements
76Os through 82Pb. Although it is possible to perform
MAD experiments that utilize L edges of each of these
elements, their anomalous properties differ substantially.
Elements 76Os through 79Au have substantial LIII white
lines, but 80Hg has a relatively flat spectrum, somewhat
diminishing the value of dispersive differences in MAD
experiments. Nonetheless, it should be noted that 80Hg is
the second most-used element for MAD, trailing only sele-
nium. This underscores the point that experiments utiliz-
ing L edge transitions, in general, are preferable to K-edge
experiments because of the larger absolute signal at the L
edge. Although the Se K edge provides a well-defined
spectrum for choosing wavelengths to maximize dispersive
differences, the peak f′′ value for Se is on the order of only
6 e–. As a general rule, LIII edges have superior transition
and white line intensities than the corresponding LI and
LII edges. However, the LI and LII edges fall at higher
energies. Thus an experiment out of range because of air
absorption problems at LIII might in some cases be feasi-
ble for the same crystal using the LI or LII edge [16]. 
The inglorious history of heavy-atom screening
Crystallography has sometimes been likened (by non-crys-
tallographers) to a modern day alchemy, in which strange
and devious incantations are uttered over protein solutions
to induce crystallization, and obscure witchcraft is
employed to coax derivatization reactions. This reputation
was certainly enhanced by the mostly anecdotal method of
early derivative screening. In general, properties of crys-
tals incubated with a potential derivatization compound
were observed, and a particular behavior would suggest
whether to proceed to the ultimate step of X-ray analysis.
The problem is that the properties observed often corre-
lated only poorly with the likelihood of derivatization. 
For example, many phasing compounds are colored, and
crystal color change has therefore been used as an indica-
tor of derivatization. However, it has been found that
many heavy atom compounds bind non-specifically to the
surface of proteins in the crystal (or to hydrophobic areas
on denatured protein that often forms the ‘skin’ that
covers many crystals). This non-specific binding does not
produce ordered sites, and is of no value for crystallo-
graphic purposes. These problems severely limit the use-
fulness of color change to evaluate derivatization.
Another method relied on estimating the density of a
crystal by the subjective speed with which it falls in a
liquid-filled capillary. Heavy phasing atoms, it was rea-
soned, would increase the protein crystal density, thus
causing faster sinking [18] –— an experiment Gallileo
might have been proud of, but hardly rigorous or
amenable to high-throughput application.
One of the most striking ‘negative’ results of a derivatization
experiment is crystal cracking or even complete dissolution.
Crystal cracking is often indicative of derivatization at a
lattice contact, denaturation of the crystallized protein, or
induction of a conformational change that cannot be accom-
modated within the crystal lattice. Although this can be an
unhappy result, it can frequently provide a starting point for
improvement. Lower concentrations of derivatization com-
pound can be used, or less-reactive compounds from the
same series. For example K2Pt(CN)4 is generally less reac-
tive than its counterpart K2PtBr4. The character of leaving
groups in common heavy-atom compounds can often dictate
activity levels [3], with activity descending in the following
order: F > Cl > Br > I > CN. Covalent cross-linking before
soaking by gentle vapor diffusion of glutaraldehyde [19] will
often prevent crystal cracking, but does not always result in
a derivatized crystal with the desired diffraction properties. 
Scanning for derivatives by analysis of X-ray data
The most definitive way to assess the formation of useful
derivatives is through X-ray analysis. Classically, a preces-
sion photograph of a particular zone, hk0 for example,
would be compared for each potential derivative crystal.
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These photographs could then be evaluated for lattice
change and intensity changes — usually gauged visually
for ‘intensity reversals’ of adjacent spots. This was a time
consuming and often inexact endeavor.
Modern detectors have improved this process, enabling
more rigorous comparison of data acquired from native and
potential derivative crystals. This does not necessarily
entail the collection of entire data sets; often the process
can be streamlined by collecting only small ‘swaths’ of
data, and analyzing these statistically. Description of this
analysis is beyond the scope of this review, however it is
worthy of note here that the main complication in these
analyses comes from non-isomorphism in analysis between
native and potential derivative crystals. Non-isomorphism
can easily be mistaken for isomorphous differences. To
obviate this problem, it is often best to analyze anomalous
signals by collecting 5–10° of data and their corresponding
Bijvoet mates using inverse-beam geometry. 
Systematic experiments prior to X-ray exposure
Although the most definitive assay for phasing atom
derivatization is the examination of X-ray data, this is a
time-consuming process. Two simple chemical methods
can be used to pre-screen dozens of potential heavy-atom
derivatives in only a few hours, with a relatively high
degree of accuracy and using no crystals. Firstly, native
polyacrylamide gel electrophoresis (PAGE) of protein and
heavy-atom mixtures can be used to search for gel shifts
upon derivatization. This technique can show which
reagents cause protein denaturation and are therefore less
likely to be useful as heavy-atom derivatives. This
method is valuable for both covalent and non-covalent
derivatives. Secondly, mass spectrometry can be used to
assay the formation of covalent complexes between
protein and heavy atom reagent. These experiments can
be performed in a highly parallel and efficient way.
Native gel electrophoresis experiments
Native PAGE separates proteins on the basis of net
charge, size and conformation [20]. To first approximation,
mobility in a native gel will be proportional to the quotient
(net charge)/(frictional coefficient), where the frictional
coefficient is closely correlated to molecular size. Single-
charge differences are often clearly resolved; for example
the phosphorylation of a protein often results in increased
mobility because of the addition of a negatively charged
phosphate group (e.g., [21]). The frictional coefficient
resulting from addition of a small molecule is usually
imperceptibly small, such that gel shifts originate primarily
from charge differences. ‘Laddering’ patterns often indi-
cate the presence of multiple discretely charged states. 
Molecular changes caused by phasing atom derivatization
can often be clearly observed on native gels. Native PAGE
is also an easy method for determining whether or not a
protein is properly folded, as a denatured protein will  not
usually enter the gel. Interactions with heavy-atom  com-
pounds commonly cause protein denaturation, and this
often correlates with a loss of diffraction in similarly treated
crystals. The concentration of derivatization reagent can be
important to the behavior of these reactions. In the event
that denaturation is observed, lower concentrations can be
screened by gel analysis. Conversely, higher concentrations
can be tried where no effect or incomplete derivatization is
observed. Native PAGE is rapid and easy to perform
(~1 hour). Literally dozens of heavy-atom conditions can
be screened in a short time by application of this tech-
nique. Although proof of useful derivatization (the pres-
ence of ordered heavy-atom sites) still relies on diffraction
analysis, this initial pre-screening process can provide a
great increase in the efficiency of finding derivatives.
An example application of native gel screening is shown in
Figure 1. Derivatization of the trimeric protein Acrp30 [22]
was analyzed using native PHAST gels (Amersham Phar-
macia Biotech). The data shown here correspond to about
one third of the compounds screened in an afternoon. Clear
band shifts are observed for Hg acetate, PIP, and YbCl3.
Note that the band shifts observed in these cases result
from a retardation of mobility, as would be expected from
the complexation of positively charged ions (e.g. Yb3+) with
the protein. No band shift is observed for K2Pt(CN)4,
EMTS or K2IrCl6. X-ray analysis shows that all of the 
compounds eliciting band shifts did indeed form specific
derivatives (see difference Fourier maps, Figure 2). The
compounds that did not cause a band-shift did not deriva-
tize the protein, with the exception of K2IrCl6. Although
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Figure 1
Native PAGE analysis of derivatization reactions. 2 µl of the protein
Acrp30 (2 mg/ml) was mixed with 2 µl of derivatization solution
(10 mM phasing atom compound in 10 mM bis-tris, pH 6.0) and left on
ice for 10 min. Next, 1 µl of the reaction solution was loaded onto a
Phastgel Homogenous 20 (Amersham Pharmacia Biotech) and run to
250Avh using native buffer strips. 
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the iridium compound bound specifically, it probably did
not induce a change in net charge, thus accounting for the
lack of a gel shift. Data not shown include experiments
using gold compounds; we found that most of these caused
aggregation of the protein, such that it could not enter the
native gel. When Acrp30 crystals were treated with these
compounds, their diffraction properties were typically
destroyed. This is a correlated pattern that we have
observed on many occasions: a compound that denatures a
protein in solution often destroys the diffraction properties
of its crystals. We commonly use this observation in selec-
tion of derivatization compounds. In our experience, native
gel shift experiments provide one of the fastest and most
reliable experiments for phasing atom screening.
Mass spectrometry
Mass spectrometry of proteins [23–25] is now commonly
used to determine the degree of protein modification by
heavy-atom compounds [26,27]. Although this technique is
extraordinarily powerful for analyzing the stoichiometry of
covalent complexes, it is not without problems. In particu-
lar, many heavy-metal compounds appear to interfere with
the desorption of the sample from the matrix associated
laser desorption ionization (MALDI) applicator chip. This
can severely impact the quality of the spectra. The MALDI
mass spectra in Figure 3 show a comparison of native and
mercury acetate-reacted forms of Acrp30. Although the
presence of the heavy atom degrades the signal, a mass
shift of ~213 Da is clearly seen. This corresponds approxi-
mately to the 200 Da mass of a single mercury atom. 
New kinds of derivatives
Since the time of Blundell and Johnson’s description [3],
many new derivatization reagents have been explored.
Some of these are essentially classical heavy-atom com-
pounds with improved properties. For example, trimethyl-
lead acetate has far better solubility and specificity
properties than its lead-based predecessors, and has become
a prominent choice for protein derivatization [28]. Derivati-
zation under pressure by the noble gas xenon — although
first described in 1965 [29] — has recently enjoyed a resur-
gence, primarily because of better pressurization equipment
[30,31]. Techniques for the derivatization of nucleic acids
have also advanced substantially [32].
In cases where the contents of the asymmetric unit is very
large, as for many multi-protein complexes, several
phasing atoms might need to be incorporated to achieve
sufficient anomalous or isomorphous signal. This need has
led to the development of metal cluster compounds for
use in phasing large structures [33]. The problem of non-
isomorphism between crystals is especially common for
crystals of large molecules. To alleviate this difficulty,
clusters of metals with substantial anomalous white line
features —  particularly Tungsten clusters — have been
developed for use in MAD phasing [33].
There have also been changes of more fundamental char-
acter in the usage of derivatization for protein crystallogra-
phy. For example, derivatization prior to crystallization has
been used to alter the surface properties of proteins recal-
citrant to crystallization to promote the formation of useful
crystals [34]. This technique has arisen because of the
advent of MAD phasing, for which the availability of an
isomorphous native crystal is irrelevant. Techniques that
rely on derivatization prior to crystallization could benefit
substantially by the application of native gel screening. In
a few cases, the resolution limits of diffraction for some
crystals have been found to improve upon derivatization.
Heavy-atom screening with poorly diffracting crystals has
been used on at least one occasion expressly for the
purpose of attaining an improved diffraction limit [35].
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Figure 2
Bijvoet difference electron density maps (5σ) of (a) Hg(C2H3O2) 2,
(b) PIP, and (c) K2IrCl6 derivatized Acrp30 crystals superimposed on a
ribbon diagram of the refined protein crystal structure (PDB entry
1C28). YbCl3 also formed an excellent derivative, although electron
density is not shown for this compound.
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Fast incorporation of halides
A rapid soak of protein crystals (on the order of 1 minute) in
a cryo-protectant solution containing up to 1 M bromide or
iodide anions can often lead to incorporation of these anom-
alously scattering centers into the ordered solvent region
around protein molecules (Figure 4) [36]. These ions bind
through electrostatic interactions with hydrophilic regions
of the protein surface. This is in marked contrast to xenon,
which tends to bind in hydrophobic cavities.
Bromide and iodide ions have suitable anomalous and
isomorphous scattering properties to provide phasing 
for protein structure solution. Bromine can be used 
for MAD because of its accessible K-absorption edge
(0.92 Å). Although no absorption edge for iodine is
within an accessible energy range for MAD, its anom-
alous signal can be useful for single wavelength anom-
alous diffraction (SAD) and SIR/AS methods. 
Halides, being small monoatomic ions, are able to substi-
tute for solvent water molecules around the protein
surface and do not show strong preference for specific
coordination geometry. In contrast, most metal ions
show a preference for a particular coordination, and do
not as easily find appropriate ordered sites. This
approach requires very little preparative effort and might
be particularly applicable for high-throughput crystallo-
graphic projects. 
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Figure 3
Mass spectrometry analysis of native and Hg(C2H3O2) 2 derivatized
Acrp30. The native protein has a mass of 16045 Da and the
Hg(C2H3O2)2 derivatized protein a mass of 16258 m/z, corresponding
to modification of the 213 Da protein. This is approximately the mass of
a single mercury atom (200 Da). The 13 Da difference must stem from
either the addition of another chemical group, or an error in the
measurement. The myoglobin standard had to be excluded from the
derivative spectra so as not to overwhelm the small signal.
Derivatization was carried out as described in Figure 2. The solution
was then diluted with 200 µl of 10 mM bis-tris pH 6.0, and, filtered
through a Microcon 10 (Amicon, Inc.) to remove unreacted
Hg(C2H3O2) 2 , 5 µl of the 30 µl retentate was then lyophilized and
redissolved in 6 µl matrix solution for MALDI analysis.
Figure 4
Difference Fourier maps produced from fast soaks with halides.
(a) Bijvoet difference Fourier map produced from a xylanase crystal
soaked in 0.5 M sodium iodide cryo-solution for 10 s. (b) Bijvoet
difference Fourier map produced from an RNAase A crystal soaked in
1 M sodium bromide cryo-solution for 40 s. The peaks are contoured at
5σ. This figure was kindly provided by K.R. Rajashankar of Brookhaven
National Laboratory.
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Application of the fast halide soak method can be used in
conjunction with other heavy-atom and anomalous scatter-
ing experiments to produce suitable phases for protein
structure determination. Because halide soaking might
result in many poorly occupied sites, it might often be dif-
ficult to determine the position of these sites with standard
Patterson or direct techniques. This approach can be used
in combination with other phasing vehicles to augment the
phase calculations, however, with the site positions deter-
mined using difference Fourier analysis. Although each
site might be poorly occupied, the aggregate phasing
power can be substantially increased over either method
alone. Because of the close proximity in energies of the
selenium and bromine K edges, these methods could con-
ceivably be combined in a single MAD experiment using
five (or more) wavelengths around these edges.
The bottom line
The famous American baseball player Yogi Berra coined
the adage, ‘It ain’t over ’til it’s over.’ Unfortunately, this
saying applies in full force to derivative screening.
Although all non-crystallographic methods, and even crys-
tallographic statistics might attest to the near certain pres-
ence of phasing atoms, only finding them by Patterson or
other methods is real proof of their usefulness in carrying
out a structure determination. The use of systematic
screening methods, such as native PAGE, however, can
rapidly provide useful leads in finding a phasing deriva-
tive, and so speed the process of structure solution.
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